Sandra Fabricatore
New York Medical College
23 Papers
38 Citations
Sandra Fabricatore is an academic researcher from New York Medical College. The author has contributed to research in topics: Transplantation & Stem cell. The author has an hindex of 4, co-authored 17 publications.
Chat about Author
Papers
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa
Mark B. Geyer,Kavita Radhakrishnan,Roger Giller,Noriko Umegaki,Sivan Harel,Maija Ht Kiuru,Maija Ht Kiuru,Kimberly D. Morel,Nicole R. LeBoeuf,Jessica J. Kandel,Anna L. Bruckner,Sandra Fabricatore,Mei Chen,David T. Woodley,John A. McGrath,Leeann Baxter-Lowe,Jouni Uitto,Angela M. Christiano,Mitchell S. Cairo +18 more
TL;DR: Two children with recessive dystrophic epidermolysis bullosa are reported to have been treated with reduced-toxicity conditioning and HLA-matched HPC transplantation.
30
A Phase I Study of Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed by Dose Escalation of Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia
Stacey Zahler,Monica Bhatia,Angela M. Ricci,Sumith Roy,Erin Morris,Lauren Harrison,Carmella van de Ven,Sandra Fabricatore,K. Wolownik,Erin Cooney-Qualter,Lee Ann Baxter-Lowe,Paul Luisi,Olga Militano,Morris Kletzel,Mitchell S. Cairo +14 more
TL;DR: Preliminary data demonstrate that RIC followed by alloHSCT and consolidation with GO appears to be safe in children and adolescents with CD33+ AML in CR1/CR2.
25
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
Deborah M. Friedman,Allen J. Dozor,Jordan Milner,Marise D'Souza,Julie-An Talano,Theodore B. Moore,Shalini Shenoy,Qiuhu Shi,Mark C. Walters,Elliott Vichinsky,Susan K. Parsons,Suzanne Braniecki,Chitti R Moorthy,Janet Ayello,Allyson Flower,Erin Morris,Harshini Mahanti,Sandra Fabricatore,Liana Klejmont,Carmella van de Ven,Lee Ann Baxter-Lowe,Mitchell S. Cairo +21 more
TL;DR: In this paper, a prospective multicenter Phase II trial of myeloimmunoablative conditioning followed by haploidentical stem cell transplantation in children with high-risk sickle cell disease (SCD) was conducted.
16
Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma.
Jessica Hochberg,Lauren Harrison,Erin Morris,Olga Militano,Phyllis Brand,Sandra Fabricatore,K. Wolownik,Mitchell S. Cairo +7 more
TL;DR: Safety of liposomal cytarabine CNS prophylaxis in children, adolescent and young adult hematopoietic stem cell transplant recipients with acute leukemia and non-Hodgkin lymphoma is confirmed.
5
Familial Haploidentical (FHI) Allogeneic Stem Cell Transplantation (AlloSCT) Utilizing CD34 Enrichment and PB MNC Addback in Children and Adolescents with High Risk Sickle Cell Disease (SCD): Rapid Engraftment, Immune Cell Reconstitution, and Sustained Donor Chimerism (IND 14359)
Janet Ayello,Yaya Chu,Carolyn A. Keever-Taylor,Julie-An Talano,Rona Singer Weinberg,Mildred Semidei-Pomlaes,Lee Ann Baxter-Lowe,Theodore B. Moore,Sandra Fabricatore,Shalini Shenoy,Cori Abikoff,Mitchell S. Cairo +11 more
TL;DR: Abikoff et al. as discussed by the authors showed that FHI CD34 enriched/PB MNC addback transplanted in pediatric recipients utilizing MUD was associated with sustained engraftment, low risk of aGVHD but limited by delayed immune reconstitution.
5